BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 33334357)

  • 1. Effects of curcumin-piperine co-supplementation on clinical signs, duration, severity, and inflammatory factors in patients with COVID-19: a structured summary of a study protocol for a randomised controlled trial.
    Miryan M; Bagherniya M; Sahebkar A; Soleimani D; Rouhani MH; Iraj B; Askari G
    Trials; 2020 Dec; 21(1):1027. PubMed ID: 33334357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of curcumin-pipeine supplementation on clinical status, mortality rate, oxidative stress, and inflammatory markers in critically ill ICU patients with COVID-19: a structured summary of a study protocol for a randomized controlled trial.
    Askari G; Alikiaii B; Soleimani D; Sahebkar A; Mirjalili M; Feizi A; Iraj B; Bagherniya M
    Trials; 2021 Jul; 22(1):434. PubMed ID: 34229742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of propolis supplementation on clinical symptoms in patients with coronavirus (COVID-19): A structured summary of a study protocol for a randomised controlled trial.
    Miryan M; Soleimani D; Dehghani L; Sohrabi K; Khorvash F; Bagherniya M; Sayedi SM; Askari G
    Trials; 2020 Dec; 21(1):996. PubMed ID: 33272309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of pomegranate juice (Punica Granatum) on inflammatory biomarkers and complete blood count in patients with COVID-19: a structured summary of a study protocol for a randomized clinical trial.
    Yousefi M; Sadriirani M; PourMahmoudi A; Mahmoodi S; Samimi B; Hosseinikia M; Saeedinezhad Z; Panahande SB
    Trials; 2021 Apr; 22(1):246. PubMed ID: 33810808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinical effect of Nano micelles containing curcumin as a therapeutic supplement in patients with COVID-19 and the immune responses balance changes following treatment: A structured summary of a study protocol for a randomised controlled trial.
    Hassaniazad M; Inchehsablagh BR; Kamali H; Tousi A; Eftekhar E; Jaafari MR; Fathalipour M; Nikoofal-Sahlabadi S; Gouklani H; Alizade H; Nikpoor AR
    Trials; 2020 Oct; 21(1):876. PubMed ID: 33092653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of boron-containing compounds and oleoylethanolamide supplementation on the recovery trend in patients with COVID-19: A structured summary of a study protocol for a randomized controlled trial.
    Tutunchi H; Mobasseri M; Pourmoradian S; Soleimanzadeh H; Kafil B; Akbari N; Monshikarimi A; Ostadrahimi A
    Trials; 2020 Oct; 21(1):890. PubMed ID: 33109244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of hydroxychloroquine on COVID-19 prevention in cancer patients undergoing treatment: a structured summary of a study protocol for a randomised controlled trial.
    Allahyari A; Rahimi H; Khadem-Rezaiyan M; Mozaheb Z; Seddigh-Shamsi M; Bary A; Kamandi M; Azimi SA; HasanAbadi SE; Noferesti A; Shariatmaghani SS; Rafatpanah H; Khatami S; Imani AJ; Mortazi H; Nodeh MM
    Trials; 2020 Jun; 21(1):575. PubMed ID: 32586363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of vitamin D and magnesium supplementation on clinical symptoms and serum inflammatory and oxidative stress markers in patients with COVID-19: a structured summary of a study protocol for a randomized controlled trial.
    Ramezani-Jolfaie N; Eftekhar E; Dadinasab M; Hesarooeyeh ZG; Pakdaman P; Razmpour F; Javedan G; Khayatian M; Azad MH; Davoodian P; Brahimi E; Rafati S; Nikoofal-Sahlabadi S; Mohammadi M
    Trials; 2023 Feb; 24(1):87. PubMed ID: 36747270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of Interferon Beta 1a, compared to Interferon Beta 1b and the usual therapeutic regimen to treat adults with moderate to severe COVID-19: structured summary of a study protocol for a randomized controlled trial.
    Irvani SSN; Golmohammadi M; Pourhoseingholi MA; Shokouhi S; Darazam IA
    Trials; 2020 Jun; 21(1):473. PubMed ID: 32493468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of COVID-19 pneumonia with glucocorticoids (CORTIVID): a structured summary of a study protocol for a randomised controlled trial.
    Les Bujanda I; Loureiro-Amigo J; Bastons FC; Guerra IE; Sánchez JA; Murgadella-Sancho A; Rey RG; López JL; Álvarez JS
    Trials; 2021 Jan; 22(1):43. PubMed ID: 33430891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the efficacy and safety of Melatonin in moderately ill patients with COVID-19: A structured summary of a study protocol for a randomized controlled trial.
    Ziaei A; Davoodian P; Dadvand H; Safa O; Hassanipour S; Omidi M; Masjedi M; Mahmoudikia F; Rafiee B; Fathalipour M
    Trials; 2020 Oct; 21(1):882. PubMed ID: 33106171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The SARS-CoV-2 Ivermectin Navarra-ISGlobal Trial (SAINT) to Evaluate the Potential of Ivermectin to Reduce COVID-19 Transmission in low risk, non-severe COVID-19 patients in the first 48 hours after symptoms onset: A structured summary of a study protocol for a randomized control pilot trial.
    Chaccour C; Ruiz-Castillo P; Richardson MA; Moncunill G; Casellas A; Carmona-Torre F; Giráldez M; Mota JS; Yuste JR; Azanza JR; Fernández M; Reina G; Dobaño C; Brew J; Sadaba B; Hammann F; Rabinovich R
    Trials; 2020 Jun; 21(1):498. PubMed ID: 32513289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of hydroxychloroquine on prevention of COVID-19 virus infection among healthcare professionals: a structured summary of a study protocol for a randomised controlled trial.
    Pirjani R; Soori T; Dehpour AR; Sepidarkish M; Moini A; Shizarpour A; Mohammad Jafari R
    Trials; 2020 Jun; 21(1):467. PubMed ID: 32493447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The efficacy of N-Acetylcysteine in severe COVID-19 patients: A structured summary of a study protocol for a randomised controlled trial.
    Rahimi A; Samimagham HR; Azad MH; Hooshyar D; Arabi M; KazemiJahromi M
    Trials; 2021 Apr; 22(1):271. PubMed ID: 33845881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the efficacy and safety of recombinant erythropoietin on the improvement of hospitalised COVID-19 patients: A structured summary of a study protocol for a randomised controlled trial.
    Samimagham HR; Azad MH; Hooshyar D; Haddad M; Arabi M; KazemiJahromi M
    Trials; 2021 Jul; 22(1):435. PubMed ID: 34229729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The efficacy and safety of Ivermectin in patients with mild and moderate COVID-19: A structured summary of a study protocol for a randomized controlled trial.
    Hosseini FS; Malektojari A; Ghazizadeh S; Hassaniazad M; Davoodian P; Dadvand H; Nikpoor AR; Nikoofal-Sahlabadi S; Kahoori S; Sepandi M; Hassanipour S; Fathalipour M
    Trials; 2021 Jan; 22(1):4. PubMed ID: 33397429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydroxychloroquine in the treatment of adult patients with Covid-19 infection in a primary care setting (LIBERTY): A structured summary of a study protocol for a randomised controlled trial.
    Vainio PJ; Hietasalo P; Koivisto AL; Kääriäinen S; Turunen J; Virtala M; Vuorinen J; Scheinin M
    Trials; 2021 Jan; 22(1):44. PubMed ID: 33430933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of Licorice on clinical symptoms and laboratory signs in moderately ill patients with pneumonia from COVID-19: A structured summary of a study protocol for a randomized controlled trial.
    Safa O; Hassani-Azad M; Farashahinejad M; Davoodian P; Dadvand H; Hassanipour S; Fathalipour M
    Trials; 2020 Sep; 21(1):790. PubMed ID: 32933552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.